Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04873401 · ClinicalTrials.gov registry record · NA
Leveraging Social Networks to Increase COVID-19 Testing Uptake
A NA study of COVID-19 and Opioid Use, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 498
- Enrollment target
- 1
- Study location
NCT04873401 is a NA study of COVID-19 and Opioid Use that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 498 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04873401, a NA study of COVID-19 and Opioid Use, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 498 participants
- Enrollment target
- 1
- Study location
Study Summary
This two-year project will adapt and conduct a trial examining the ability of two recruitment strategies, chain-referral and credible messenger, to reach those who use opioids and other substances in order to increase their uptake of onsite point of care COVID-19 testing that will be delivered in two community based organizations (CBOs): Alliance for Positive Change and Argus Health Inc. In Phase 1, Adapt two implementation strategies to support COVID-19 testing uptake and sustainability, adapting elements of existing efficacious social network-based interventions via a CBPR approach. In Phase 2, we will examine and compare the efficacy of two sets of implementation strategies on (i) reach, (ii) testing uptake, (iii) service delivery (i.e. quarantine, medical care, contact tracing) and (iv) sustainability for individuals who use opioids and other drugs. In Phase 3, Elucidate and compare the system/organizational-, staff-, and individual-level factors that influence implementation (i.e. fidelity, acceptability, feasibility, sustainability) of the strategies to develop a plan for dissemination and scale-up in other CBOs who serve opioid and other substance using individuals in NYC.
Conditions Studied
Interventions
- BEHAVIORAL Chain-referral
- BEHAVIORAL Credible Messenger
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 498 participants |
| Start Date | 2021-04-20 |
| Est. Completion | 2023-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04873401
The ClinicalTrials.gov registry entry for NCT04873401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 498 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Chain-referral is the first listed.
NCT04873401 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04873401 about?
NCT04873401 is a clinical study titled "Leveraging Social Networks to Increase COVID-19 Testing Uptake". This two-year project will adapt and conduct a trial examining the ability of two recruitment strategies, chain-referral and credible messenger, to reach those who use opioids and other substances in order to increase their uptake of onsite point of care COVID-19 testing that will be delivered in tw...
What is the current status of trial NCT04873401?
This trial is currently completed. It is a NA study. The enrollment target is 498 participants. The study started on 2021-04-20. Estimated completion is 2023-01-01.
What conditions does trial NCT04873401 study?
This clinical trial studies the following conditions: COVID-19, Opioid Use, Substance Use.
What interventions are being tested in trial NCT04873401?
The interventions under investigation include: Chain-referral (BEHAVIORAL), Credible Messenger (BEHAVIORAL).
Who is sponsoring clinical trial NCT04873401?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04873401 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.